Suslan Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets %
About Suslan Bioscience
Suslan Bioscience Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 August 2014 and has a history of Ten years and five months. Its registered office is in Aurangabad, Maharashtra, India.
The Corporate was formerly known as Sanman Engineering Automation Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Balaji Shinde and Sudhirchandra Kadam serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2014PTC257346
-
Company No.
257346
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Aug 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Suslan Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhirchandra Kadam
|
Director | 19-Aug-2014 | Current |
|
Balaji Shinde
|
Director | 19-Aug-2014 | Current |
Financial Performance of Suslan Bioscience.
Suslan Bioscience Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suslan Bioscience?
In 2021, Suslan Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ambika Engineering And Springs LlpBalaji Shinde is a mutual person
-
Sanman Automoble Engineering Private Limited
Balaji Shinde is a mutual person
-
Planet Inn Private Limited
Balaji Shinde is a mutual person
-
Lanus Pharmaceuticals Limited
Sudhirchandra Kadam is a mutual person
-
R.N. Wellness Private Limited
Sudhirchandra Kadam is a mutual person
-
Kadam Pharma Private Limited
Sudhirchandra Kadam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Suslan Bioscience?
Unlock and access historical data on people associated with Suslan Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suslan Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suslan Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
